Literature DB >> 11054964

Lymph node pathology. Benign proliferative, lymphoma, and metastatic disease.

O Sakai1, H D Curtin, L V Romo, P M Som.   

Abstract

The evaluation of cervical lymph nodes is one of the main indications for performing CT and MR imaging of the neck. Imaging may be done for evaluation of an unknown neck mass, but more commonly the neck is imaged to evaluate potential metastasis from a known mucosal malignancy. CT and MR imaging characteristics of both malignant and nonmalignant nodal diseases are reviewed and the differential diagnosis of nodal pathologies for specific imaging findings are discussed. A recently proposed imaging-based nodal classification for metastatic nodal diseases from head and neck cancer is also described.

Entities:  

Mesh:

Year:  2000        PMID: 11054964     DOI: 10.1016/s0033-8389(05)70216-5

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  19 in total

1.  [(18)F]-FDG PET/CT imaging for detection of nodal metastases in patients with squamous cell carcinoma of the pharynx and larynx: comparison with CT.

Authors:  Yuko Suenaga; Kazuhiro Kitajima; Tomonori Kanda; Naoki Otsuki; Ken-Ichi Nibu; Ryohei Sasaki; Tomoo Itoh; Kazuro Sugimura
Journal:  Jpn J Radiol       Date:  2015-12-15       Impact factor: 2.374

2.  PET/CT for staging and follow-up of pediatric nasopharyngeal carcinoma.

Authors:  Daniel K L Cheuk; Noah D Sabin; Moinul Hossain; Amy Wozniak; Mihir Naik; Carlos Rodriguez-Galindo; Matthew J Krasin; Barry L Shulkin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-04-25       Impact factor: 9.236

3.  Role of diffusion-weighted MR imaging in cervical lymphadenopathy.

Authors:  Ahmed Abdel Khalek Abdel Razek; Nermin Yehia Soliman; Sahar Elkhamary; Mousa K Alsharaway; Ali Tawfik
Journal:  Eur Radiol       Date:  2006-03-24       Impact factor: 5.315

4.  CT differentiation of enlarged mediastinal lymph node due to anthracosis from metastatic lymphadenopathy: a comparative study proven by endobronchial US-guided transbronchial needle aspiration.

Authors:  Johannes Kirchner; Michael Broll; Phillip Müller; Natalia Pomjanski; Stepfan Biesterfeld; Dieter Liermann; Ralph Kickuth
Journal:  Diagn Interv Radiol       Date:  2015 Mar-Apr       Impact factor: 2.630

5.  Nontuberculous mycobacterial lymphadenitis of the head and neck: radiologic observations and clinical context.

Authors:  Sandeep Bagla; David Tunkel; Michael A Kraut
Journal:  Pediatr Radiol       Date:  2003-04-12

6.  CT, MR, US,18F-FDG PET/CT, and their combined use for the assessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck.

Authors:  Dae Young Yoon; Hee Sung Hwang; Suk Ki Chang; Young-Soo Rho; Hwoe Young Ahn; Jin Hwan Kim; In Jae Lee
Journal:  Eur Radiol       Date:  2008-10-09       Impact factor: 5.315

7.  A mathematical model using computed tomography for the diagnosis of metastatic central compartment lymph nodes in papillary thyroid carcinoma.

Authors:  Tianrun Liu; Xuan Su; Weichao Chen; Lie Zheng; Li Li; AnKui Yang
Journal:  Eur Radiol       Date:  2014-08-09       Impact factor: 5.315

8.  MR imaging prediction of local control of nasopharyngeal carcinoma treated with radiation therapy and chemotherapy.

Authors:  Y Wang; H Zhao; Z-Q Zhang; L-L Huang; Y Ye; Y-B Wang; M-J Han
Journal:  Br J Radiol       Date:  2014-05-14       Impact factor: 3.039

9.  Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer.

Authors:  R M Subramaniam; M Truong; P Peller; O Sakai; G Mercier
Journal:  AJNR Am J Neuroradiol       Date:  2009-11-12       Impact factor: 3.825

10.  Detection of neck recurrence in patients with differentiated thyroid cancer: comparison of ultrasound, contrast-enhanced CT and (18)F-FDG PET/CT using surgical pathology as a reference standard: (ultrasound vs. CT vs. (18)F-FDG PET/CT in recurrent thyroid cancer).

Authors:  Young Lan Seo; Dae Young Yoon; Sora Baek; You Jin Ku; Young-Soo Rho; Eun-Jae Chung; Sung Hye Koh
Journal:  Eur Radiol       Date:  2012-05-05       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.